Black and White Adults With CKD Hospitalized With Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.


Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
11 2022
Historique:
received: 13 10 2021
accepted: 21 02 2022
pubmed: 12 4 2022
medline: 26 10 2022
entrez: 11 4 2022
Statut: ppublish

Résumé

Few studies have investigated racial disparities in acute kidney injury (AKI), in contrast to the extensive literature on racial differences in the risk of kidney failure. We sought to study potential differences in risk in the setting of chronic kidney disease (CKD). Prospective cohort study. We studied 2,720 self-identified Black or White participants with CKD enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study from July 1, 2013, to December 31, 2017. Self-reported race (Black vs White). Hospitalized AKI (≥50% increase from nadir to peak serum creatinine). Cox regression models adjusting for demographics (age and sex), prehospitalization clinical risk factors (diabetes, blood pressure, cardiovascular disease, estimated glomerular filtration rate, proteinuria, receipt of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers), and socioeconomic status (insurance status and education level). In a subset of participants with genotype data, we adjusted for apolipoprotein L1 gene (APOL1) high-risk status and sickle cell trait. Black participants (n = 1,266) were younger but had a higher burden of prehospitalization clinical risk factors. The incidence rate of first AKI hospitalization among Black participants was 6.3 (95% CI, 5.5-7.2) per 100 person-years versus 5.3 (95% CI, 4.6-6.1) per 100 person-years among White participants. In an unadjusted Cox regression model, Black participants were at a modestly increased risk of incident AKI (HR, 1.22 [95% CI, 1.01-1.48]) compared with White participants. However, this risk was attenuated and no longer significant after adjusting for prehospitalization clinical risk factors (adjusted HR, 1.02 [95% CI, 0.83-1.25]). There were only 11 AKI hospitalizations among individuals with high-risk APOL1 risk status and 14 AKI hospitalizations among individuals with sickle cell trait. Participants were limited to research volunteers and potentially not fully representative of all CKD patients. In this multicenter prospective cohort of CKD patients, racial disparities in AKI incidence were modest and were explained by differences in prehospitalization clinical risk factors.

Identifiants

pubmed: 35405207
pii: S0272-6386(22)00583-2
doi: 10.1053/j.ajkd.2022.02.021
pmc: PMC9547036
mid: NIHMS1800770
pii:
doi:

Substances chimiques

Angiotensin-Converting Enzyme Inhibitors 0
Angiotensins 0
APOL1 protein, human 0
Apolipoprotein L1 0
Creatinine AYI8EX34EU

Types de publication

Multicenter Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

610-618.e1

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060963
Pays : United States
Organisme : NIDDK NIH HHS
ID : U2C DK114886
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024131
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061022
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK119199
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000003
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000439
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060990
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK114857
Pays : United States
Organisme : NIDDK NIH HHS
ID : K24 DK092291
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR029879
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061028
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000433
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL153161
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK119562
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060984
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061021
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK060990
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060980
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000424
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR016500
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109036
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060902
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK114014
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK120811
Pays : United States

Investigateurs

Lawrence J Appel (LJ)
Jing Chen (J)
Debbie L Cohen (DL)
James P Lash (JP)
Robert G Nelson (RG)
Mahboob Rahman (M)
Panduranga S Rao (PS)
Vallabh O Shah (VO)
Mark L Unruh (ML)

Informations de copyright

Copyright © 2022 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Références

Hemoglobin. 2014;38(1):28-32
pubmed: 24099594
Bioinformatics. 2013 Nov 1;29(21):2744-9
pubmed: 23956302
N Engl J Med. 2021 Nov 4;385(19):1737-1749
pubmed: 34554658
Obstet Gynecol. 2018 May;131(5):899-908
pubmed: 29630020
PLoS Med. 2020 Dec 11;17(12):e1003470
pubmed: 33306688
J Diabetes Complications. 2016 Aug;30(6):1129-36
pubmed: 27105934
J Am Soc Nephrol. 2017 Jul;28(7):2180-2187
pubmed: 28280138
J Crit Care. 2012 Oct;27(5):496-504
pubmed: 22591570
N Engl J Med. 2013 Dec 5;369(23):2183-96
pubmed: 24206458
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Semin Nephrol. 2013 Sep;33(5):409-15
pubmed: 24119846
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8
pubmed: 30798791
J Cardiothorac Vasc Anesth. 2020 Dec;34(12):3314-3320
pubmed: 32434723
Am J Hum Genet. 2012 Nov 2;91(5):794-808
pubmed: 23103231
J Arthroplasty. 2019 Jun;34(6):1240-1243
pubmed: 30824293
Br J Haematol. 2019 May;185(3):532-540
pubmed: 30859563
Clin J Am Soc Nephrol. 2009 Aug;4(8):1302-11
pubmed: 19541818
J Am Soc Nephrol. 2016 Sep;27(9):2576-95
pubmed: 27178804
Am J Kidney Dis. 2015 Oct;66(4):602-12
pubmed: 25975964
J Am Soc Nephrol. 2006 Apr;17(4):1135-42
pubmed: 16495381
JAMA. 2014 Nov 26;312(20):2115-25
pubmed: 25393378
JAMA Cardiol. 2017 Sep 1;2(9):967-975
pubmed: 28724126
J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S148-53
pubmed: 12819321
Am J Kidney Dis. 2011 Aug;58(2):214-27
pubmed: 21705121
J Am Soc Nephrol. 2020 Aug;31(8):1836-1846
pubmed: 32576601
Lancet. 1970 Feb 28;1(7644):450-2
pubmed: 4189754
J Am Soc Nephrol. 2021 Jan;32(1):33-40
pubmed: 33214201
J Am Soc Nephrol. 2020 Aug;31(8):1688-1695
pubmed: 32561682
J Am Soc Nephrol. 2010 Oct;21(10):1757-64
pubmed: 20671214
Kidney Int. 2005 Sep;68(3):914-24
pubmed: 16105022
Curr Opin Nephrol Hypertens. 2011 May;20(3):211-7
pubmed: 21455065
Ann Intern Med. 2001 Sep 4;135(5):352-66
pubmed: 11529699
J Am Soc Nephrol. 2019 Jul;30(7):1271-1281
pubmed: 31235617
Semin Nephrol. 2015 May;35(3):222-36
pubmed: 26215860
J Am Soc Nephrol. 2017 Mar;28(3):923-934
pubmed: 27729571
Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1723-31
pubmed: 26336912
J Am Soc Nephrol. 2021 Mar;32(3):654-662
pubmed: 33443096
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2073-83
pubmed: 26265715
Clin J Am Soc Nephrol. 2021 Mar 8;16(3):348-355
pubmed: 33648973
Am J Med. 2009 Jun;122(6):507-12
pubmed: 19393983
J Am Soc Nephrol. 2014 Aug;25(8):1615-7
pubmed: 24722441
Am J Kidney Dis. 2015 Oct;66(4):591-601
pubmed: 25943717
Nat Rev Nephrol. 2020 Oct;16(10):565-567
pubmed: 32753739
J Am Soc Nephrol. 2014 Aug;25(8):1834-41
pubmed: 24722442
Clin J Am Soc Nephrol. 2016 Jan 7;11(1):14-20
pubmed: 26683890
J Am Soc Nephrol. 2011 Sep;22(9):1721-8
pubmed: 21868498
Kidney Int. 2008 Jul;74(1):101-7
pubmed: 18385668
Clin J Am Soc Nephrol. 2014 Apr;9(4):682-9
pubmed: 24458075

Auteurs

Anthony N Muiru (AN)

Division of Nephrology, Department of Medicine, University of California, San Francisco, California. Electronic address: anthony.muiru@ucsf.edu.

Jingrong Yang (J)

Division of Research, Kaiser Permanente Northern California, Oakland, California.

Vimal K Derebail (VK)

UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.

Kathleen D Liu (KD)

Division of Nephrology, Department of Medicine, University of California, San Francisco, California.

Harold I Feldman (HI)

Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Anand Srivastava (A)

Division of Nephrology and Hypertension, Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Zeenat Bhat (Z)

Department of Medicine, Wayne State University, Detroit, Michigan.

Santosh L Saraf (SL)

Department of Medicine, University of Illinois, Chicago, Illinois.

Teresa K Chen (TK)

Department of Medicine, Johns Hopkins University, Baltimore, Maryland.

Jiang He (J)

Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.

Michelle M Estrella (MM)

Division of Nephrology, Department of Medicine, University of California, San Francisco, California.

Alan S Go (AS)

Division of Research, Kaiser Permanente Northern California, Oakland, California.

Chi-Yuan Hsu (CY)

Division of Nephrology, Department of Medicine, University of California, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Oakland, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH